3 not yet recruiting, 2 completed, 2 recruiting, 1 unknown. 5 Not applicable, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Recruiting 2, Completed 1, Not yet recruiting 1, Unknown 1 |
| Phase 2 | 3 | Not yet recruiting 2, Completed 1 |
Follow Ampullary Carcinoma: new trials by email Literature Review of Ampullary Carcinoma trials Research Report on Ampullary Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract Cancer Daraxonrasib - Biliary Tract Cancers, Intrahepatic Cholangiocarcinoma (Icc) | Phase 2 | Not yet recruiting | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 55 | 2026-11-01 | 2026-08-28 |
| Modified Single-Incision Plus One-Port Versus Conventional Five-Port Laparoscopic Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas Modified Single Incision plus one-port Laparoscopic Pancreaticoduodenectomy, Conventional Laparoscopic Pancreaticoduodenectomy - Ampullary Carcinoma, Duodenal Adenocarcinoma | Not applicable | Recruiting | Nanfang Hospital, Southern Medical University | 232 | 2026-06-04 | 2026-08-04 |
| Effect of Negative-Pressure Drainage Versus Pancreatic Duct Stenting for Preventing Pancreatitis After Endoscopic Papillectomy for Duodenal Papillary Tumors Placement of a negative pressure drainage tube, Placement of a pancreatic duct stent - Ampulla of Vater Neoplasms, Ampullary Adenoma | Not applicable | Not yet recruiting | Cui Xiaobing | 132 | 2026-03-20 | 2026-03-04 |
| Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy Open Pancreaticoduodenectomy, Laparoscopic Pancreaticoduodenectomy - Pancreatic Ductal Adenocarcinoma, Ampullary Carcinoma | Not applicable | Recruiting | Minia University | 90 | 2026-01-17 | 2026-01-21 |
| Surufatinib Combined With Toripalimab and AG Regiments for First-line Treatment of Unresectable or Relapsing Metastatic Ampullary Carcinoma Surufatinib+Toripalimab+AG - Ampullary Carcinoma | Phase 2 | Not yet recruiting | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 30 | 2023-10-01 | 2023-10-02 |
| Radioactive Stents for Treatment of Unresectable Biliary Tract Cancer radioactive stent, plastic stent - Intrahepatic Cholangiocarcinoma, Cholangiocarcinoma of the Extrahepatic Bile Duct | Not applicable | Unknown | 307 Hospital of PLA | 140 | 2014-08-01 | 2014-09-12 |
| Endobiliary RFA for Unresectable Malignant Biliary Strictures Radiofrequency ablation (RFA) - Cholangiocarcinoma, Ampullary Carcinoma | Not applicable | Completed | Bing Hu | 174 | 2013-05-01 | 2020-10-14 |
| Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer ZD6474, Vandetanib, Gemcitabine, Placebo matching ZD6474 - Biliary Tract Cancer, Gallbladder Cancer | Phase 2 | Completed | Genzyme, a Sanofi Company | 174 | 2008-10-01 | 2016-10-10 |
Cholangiocarcinoma (4) · Biliary Tract Neoplasms (2) · Gallbladder Neoplasms (2) · Adenoma, Islet Cell (1) · Carcinoma (1) · Cirrhosis, Familial, with Pulmonary Hypertension (1) · Gastrointestinal Neoplasms (1) · Liver Neoplasms (1) · Neoplasm Metastasis (1)
Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms, Glandular and Epithelial (5) · Adenocarcinoma (4) · Carcinoma (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Neoplasms by Site (3) · Biliary Tract Diseases (2) · Gallbladder Diseases (2) · Adenoma (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Gastrointestinal Diseases (1) · Liver Diseases (1)
Gemcitabine (1) · Radiofrequency Ablation (1) · vandetanib (1)
307 Hospital of PLA (1) · Bing Hu (1) · Cui Xiaobing (1) · Genzyme, a Sanofi Company (1) · Minia University (1) · Nanfang Hospital, Southern Medical University (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)
China (3) · Egypt (1) · Italy (1) · United States (1)
Bing Hu, MD, PhD (1) · Nilo Azad, MD (1) · Saleh K Saleh, MD (1) · Yan Liu, Doctor (1)